4SEPTEMBER - 2022TECH OUTLOOKIN MY OPINION12LAST WORDThree C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientNick Thomson, Senior Director, Chemical Research & Development, Pfizer [NYSE:PFE]08Avoiding the `Shiny Object' Trap of Digital TransformationTimothy White, Vice President & Head of Global Digital Commercial, Teva Pharmaceuticals30COV ER STORYSetting the Base for Generics Development and Day-one LaunchPharmacare Premium Pharmacare Premium Hani Sarraf, Director of Business Development
< Page 3 | Page 5 >